Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 

Puralube Opthalmic Ointment 1X3.5 Gm Mfg.By:Perrigo Pharma

Image 0 of Puralube Opthalmic Ointment 1X3.5 Gm Mfg.By:Perrigo PharmaImage 1 of Puralube Opthalmic Ointment 1X3.5 Gm Mfg.By:Perrigo PharmaImage 2 of Puralube Opthalmic Ointment 1X3.5 Gm Mfg.By:Perrigo Pharma

Puralube Opthalmic Ointment 1X3.5 Gm Mfg.By:Perrigo Pharma


UPC No.:348102017350 Mfg. Item No.:001735 Item Profile
Item No.B10148324
Ndc 48102001735 305744025358
Selling Size : 3.5 GM
Selling UoM : EA
NDC: 00574-4025-35
UPC Barcode : 3-05744-02535-8
Supplier: 0050001922 PERRIGO CO
Supplier Material : 402535
Fine Line Class : 190019201922 Dry Eye Relief
Product Category : OT Over the Counter
Product Type : OTC Branded OTC

Have a question?


Product Description.:

Fera Pharmaceuticals Launches OTC Puralube(R) Ophthalmic Ointment

Puralube, a preservative free ophthalmic ointment, is one that has been relied upon by patients and healthcare professionals for years to relieve the symptoms of dry eye. When the original manufacturer of Puralube discontinued the product, Fera was inundated with requests to bring the product back.

Frank DellaFera, President of Fera states, "Puralube is a product that fits perfectly with our eye care portfolio. We are so pleased to make Puralube available again, giving patients, pharmacists and physicians a cost effective and reliable treatment option for dry eye symptoms".

Fera is launching Puralube in a 3.5 g tube as well as a carton of 20 1 g tubes. It will be available through retail, wholesale and mail order pharmacy.

About Dry Eye

Dry eye currently affects almost 21 million Americans, and yet, only 2.5 million patients are actually being treated for it according to experts. Dry eye, if not treated properly, can lead to serious eye problems.

About Fera Pharmaceuticals, LLC

Fera Pharmaceuticals is a privately held company. The company goal is to? realize opportunities via acquisitions, in-licensing, developing? and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on? niche markets. Fera also currently markets several prescription ophthalmic ointments including Bacitracin, Garamycin� and Ilotycin� as well as Neptazane� tablets.

For more information visit